ZTS

Q: What is the price of Zoetis (ZTS) today?

The price of Zoetis (ZTS) today is R$ 838,96, with a variation of -13.52% compared to the last year. The price of Zoetis (ZTS) started the year trading around R$ 883,08 and today it is at R$ 838,96. Follow the real-time price chart, the historical price of Zoetis (ZTS), and stock data from Ibovespa and international markets.

Q: When does Zoetis (ZTS) pay dividends?

Zoetis (ZTS) distributed dividends in the last year,in the months of March, June, September e December totaling R$ 9,37. The Dividend Yield for the last 12 months is 1,19%.

Q: Zoetis (ZTS) is it worth it?

Currently, Zoetis (ZTS) is priced at R$ 838,96, with a P/E of 26,68%, representing a deviation of 36,15% from its historical average P/E. In the last year, the stock showed a variation of -13.52% in its price and distributed R$ 9,37 in dividends, resulting in a Dividend Yield of 1,19%. The total shareholder return was -13,52%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Zoetis (ZTS)?

Investing in shares of Zoetis (ZTS) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Zoetis (ZTS) yield today?

The yield of Zoetis (ZTS) was 1,76% in the last month, -13,52% in the last year and 1,05% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 10,10 in dividends, um Dividend Yield de 1,19%.If you wanted to buy 100 shares of Zoetis (ZTS) today, the total investment would be based on the current price of R$ 838,96.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 72.553,42In 5 years: R$ 84.777,09In 10 years: 312.848,86It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Zoetis Inc.

Price

US$ 154,79

variation (12m)

-13,52%

p/l

26,68

p/vp

14,00

DIVIDEND YIELD

1,19%

quote ZTS

BVMF

ZTS

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of ZTS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,76%

3 months

-6,41%

1 year

-13,52%

2 years

-15,22%

5 years

1,05%

10 years

272,90%

real profitability

profitability minus inflation.

1 month

1,76%

3 months

-6,88%

1 year

-17,83%

2 years

-22,72%

5 years

-26,16%

10 years

121,07%

Indicators ZTS

check out the fundamentals of Zoetis shares

P/L

26,68

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

7,43

Sector: -3,77 Industry: -3,77

P/VP

14,00

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

1,19%

Sector: - Industry: -

ROA

18,04%

Sector: -63,50% Industry: -63,50%

ROE

52,48%

Sector: -67,23% Industry: -67,23%

ROIC

28,37%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

27,83%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

71,45%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

37,51%

Sector: -43,21% Industry: -43,21%

P/EBITDA

17,34

Sector: -3,13 Industry: -3,13

P/EBIT

19,73

Sector: -3,41 Industry: -3,41

P/ASSETS

4,81

Sector: 1,29 Industry: 1,29

VPA

11,18

Sector: 1,80 Industry: 1,80

LPA

5,87

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,34

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

7,05%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

9,78%

Sector: - Industry: -

FAIR PRICE OF Zoetis ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 154,79

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-75,18%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

ZTS indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%
HRMY	11,93	2,79	23,40%	0,00%	US$ 2,16 B	23,42%

comparison of ZTS with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history ZTS dividend history

Current DY: 1,19%

5-year average DY: 0,74%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	18/07/2025	03/09/2025	0,50000000
Dividends	21/04/2025	03/06/2025	0,50000000
Dividends	21/01/2025	04/03/2025	0,50000000
Dividends	31/10/2024	03/12/2024	0,43200000
Dividends	18/07/2024	04/09/2024	0,43200000
Dividends	19/04/2024	04/06/2024	0,43200000
Dividends	19/01/2024	01/03/2024	0,43200000
Dividends	01/11/2023	01/12/2023	0,37500000
Dividends	21/07/2023	01/09/2023	0,37500000
Dividends	21/04/2023	01/06/2023	0,37500000
Dividends	20/01/2023	01/03/2023	0,37500000
Dividends	01/11/2022	01/12/2022	0,32500000
Dividends	21/07/2022	01/09/2022	0,32500000
Dividends	21/04/2022	01/06/2022	0,32500000
Dividends	20/01/2022	01/03/2022	0,32500000
Dividends	29/10/2021	01/12/2021	0,25000000
Dividends	21/07/2021	01/09/2021	0,25000000
Dividends	21/04/2021	01/06/2021	0,25000000
Dividends	20/01/2021	01/03/2021	0,25000000
Dividends	21/10/2020	01/12/2020	0,20000000
Dividends	17/07/2020	01/09/2020	0,20000000
Dividends	17/04/2020	01/06/2020	0,20000000
Dividends	17/01/2020	03/03/2020	0,20000000
Dividends	22/10/2019	02/12/2019	0,16400000
Dividends	19/07/2019	03/09/2019	0,16400000
Dividends	18/04/2019	03/06/2019	0,16400000
Dividends	18/01/2019	01/03/2019	0,16400000
Dividends	20/11/2018	03/12/2018	0,12600000
Dividends	20/07/2018	04/09/2018	0,12600000
Dividends	20/04/2018	01/06/2018	0,12600000
Dividends	19/01/2018	01/03/2018	0,12600000
Dividends	09/11/2017	01/12/2017	0,10500000
Dividends	15/06/2017	01/09/2017	0,10500000
Dividends	06/04/2017	01/06/2017	0,10500000
Dividends	20/01/2017	01/03/2017	0,10500000
Dividends	03/11/2016	01/12/2016	0,09500000
Dividends	30/06/2016	30/08/2016	0,09500000
Dividends	07/04/2016	01/06/2016	0,09500000
Dividends	21/01/2016	01/03/2016	0,09500000
Dividends	05/11/2015	01/12/2015	0,08300000
Dividends	13/08/2015	01/09/2015	0,08300000
Dividends	09/04/2015	02/06/2015	0,08300000
Dividends	22/01/2015	03/03/2015	0,08300000
Dividends	05/11/2014	02/12/2014	0,07200000
Dividends	20/08/2014	02/09/2014	0,07200000
Dividends	28/04/2014	02/06/2014	0,07200000
Dividends	30/01/2014	04/03/2014	0,07200000
Dividends	01/11/2013	02/12/2013	0,06500000
Dividends	01/08/2013	02/09/2013	0,06500000
Dividends	01/05/2013	06/06/2013	0,06500000

ABOUT THE COMPANY Zoetis

Zoetis Inc.

Average user rating I10

5.0 (54 people)

Estados Unidos

13 years

Foundation: 2012

2013

Year of debut on the stock exchange - 12 years

11.300

Employees

The Company Zoetis Inc. (Estados Unidos), is listed on NYSE with a market value of $ 69,70 Billions, having a net worth of $ 4,98 Billions.

With a total of 11.300 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 9,39 Billions, which generated a profit in the amount of $ 2,61 Billions.

As for its main indicators, the Company has a P/E ratio of 26,68, a P/B ratio of 14,00 and in the last 12 months the dividend yield of ZTS was at 1,19%.

The Company is traded in Brazil through the BDR Z1TS34, or can be purchased on abroad through the ticker ZTS.

Market value

US$ 69,70 Billions

Net worth

US$ 4,98 Billions

US$ 4.977.000.000,00

Assets

US$ 14,48 Billions

US$ 14.479.000.000,00

Total Number of Shares

445,00 Milhões

445.000.000

Average Daily Trading Volume

US$ 3,25 Milhões

US$ 3.253.338,46

Sector

Cuidados de saúde

Industry

Biotecnologia

ZTS

ZTS revenue and profits

ZTS results

DRAG THE FRAME TO SEE MORE DATA

ZTS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Zoetis (ZTS) today?

The price of Zoetis (ZTS) today is R$ 838,96, with a variation of -13.52% compared to the last year. The price of Zoetis (ZTS) started the year trading around R$ 883,08 and today it is at R$ 838,96. Follow the real-time price chart, the historical price of Zoetis (ZTS), and stock data from Ibovespa and international markets.

When does Zoetis (ZTS) pay dividends?

Zoetis (ZTS) distributed dividends in the last year,in the months of March, June, September e December totaling R$ 9,37. The Dividend Yield for the last 12 months is 1,19%.

Zoetis (ZTS) is it worth it?

Currently, Zoetis (ZTS) is priced at R$ 838,96, with a P/E of 26,68%, representing a deviation of 36,15% from its historical average P/E. In the last year, the stock showed a variation of -13.52% in its price and distributed R$ 9,37 in dividends, resulting in a Dividend Yield of 1,19%. The total shareholder return was -13,52%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Zoetis (ZTS)?

Investing in shares of Zoetis (ZTS) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Zoetis (ZTS) yield today?

The yield of Zoetis (ZTS) was 1,76% in the last month, -13,52% in the last year and 1,05% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 10,10 in dividends, um Dividend Yield de 1,19%.

If you wanted to buy 100 shares of Zoetis (ZTS) today, the total investment would be based on the current price of R$ 838,96.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 72.553,42
In 5 years: R$ 84.777,09
In 10 years: 312.848,86

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ZTS

Zoetis Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of ZTS

check out the fundamentals of Zoetis shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 1,19%

5-year average DY: 0,74%

type

date with

payment date

value

ABOUT THE COMPANY Zoetis

Zoetis Inc.

Estados Unidos

13 years

2013

11.300

PROFIT X PRICE ZTS

ZTS results

ZTS cash flow

evolution of assets - ZTS

ZTS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80